Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below Consensus

Merck & Co Inc Q2 sales reached $11.4 billion, +22% Y/Y, missing the consensus of $11.5 billion. Excluding the foreign exchange impact, revenues were up 19%, reflecting ongoing recovery from the COVID-19 pandemic and underlying solid demand.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.